| 1 |
34976330 | Big Data Information under Proportional Hazard Mathematical Model in Analysis of Hepatitis B Virus Infection Data of Patients with Interventional Liver Cancer through Antiviral Therapy of Entecavir. | 2021 |
1 |
| 2 |
32329638 | Nucleos(t)ide analogues for the treatment of chronic hepatitis B: a systematic review with network meta-analysis. | 2020 Aug |
1 |
| 3 |
33054304 | Efficacy of entecavir in treating hepatitis B virus-associated membranous nephropathy. | 2020 Nov |
1 |
| 4 |
30890501 | [Association of baseline alanine aminotransferase levels with therapeutic effects of entecavir and interferon-α in patients with chronic hepatitis B]. | 2019 Feb 28 |
1 |
| 5 |
29441755 | A Multicenter Study of the Antiviral Efficacy of Entecavir Monotherapy Compared to Lamivudine Monotherapy in Children with Nucleos(t)ide-naïve Chronic Hepatitis B. | 2018 Feb 19 |
1 |
| 6 |
28035553 | Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis. | 2017 Mar |
1 |
| 7 |
28881690 | Perioperative entecavir for patients with HBV-related hepatocellular carcinoma and low levels of viral DNA: analysis using propensity score matching. | 2017 Aug 1 |
1 |
| 8 |
27665939 | UGT2B28 genomic variation is associated with hepatitis B e-antigen seroconversion in response to antiviral therapy. | 2016 Sep 26 |
1 |
| 9 |
24419351 | Early entecavir treatment for chronic hepatitis B with severe acute exacerbation. | 2014 |
1 |
| 10 |
24583931 | Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled study. | 2014 |
1 |
| 11 |
23837141 | Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study. | 2013 Jun |
1 |
| 12 |
24058372 | Lingmao Formula Combined with Entecavir for HBeAg-Positive Chronic Hepatitis B Patients with Mildly Elevated Alanine Aminotransferase: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. | 2013 |
1 |
| 13 |
24371400 | A granulomatous drug eruption induced by entecavir. | 2013 Nov |
1 |
| 14 |
23010744 | Tenofovir monotherapy and tenofovir plus entecavir combination as rescue therapy for entecavir partial responders. | 2012 Nov |
1 |
| 15 |
23082701 | Comparison of the antiviral effects of entecavir and adefovir dipivoxil in chronic HBV infection: a randomized control trial. | 2012 Sep |
1 |
| 16 |
21112655 | Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir. | 2011 Mar |
1 |
| 17 |
21480321 | Randomized trial of lamivudine versus entecavir in entecavir-treated patients with undetectable hepatitis B virus DNA: outcome at 2 Years. | 2011 Apr |
1 |
| 18 |
20044806 | Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage. | 2010 Apr |
1 |
| 19 |
20546442 | Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patients. | 2010 May |
1 |
| 20 |
20562676 | Long-term outcome of renal transplant recipients with chronic hepatitis B infection-impact of antiviral treatments. | 2010 Aug 15 |
1 |
| 21 |
19070393 | Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy. | 2009 Feb |
1 |
| 22 |
19669332 | Entecavir for the treatment of lamivudine-refractory chronic hepatitis B patients in China. | 2007 Sep |
1 |